ImpediMed Limited
IPDQF
$0.0445
$0.004812.09%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.75% | 8.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.75% | 10.37% | |||
| Cost of Revenue | -2.75% | 6.90% | |||
| Gross Profit | -2.75% | 10.86% | |||
| SG&A Expenses | -2.75% | 21.58% | |||
| Depreciation & Amortization | -2.75% | 106.08% | |||
| Other Operating Expenses | -2.74% | -78.96% | |||
| Total Operating Expenses | -2.75% | 7.37% | |||
| Operating Income | 2.75% | -5.87% | |||
| Income Before Tax | 2.75% | -12.55% | |||
| Income Tax Expenses | -2.70% | -13.95% | |||
| Earnings from Continuing Operations | 2.74% | -12.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.74% | -12.52% | |||
| EBIT | 2.75% | -5.87% | |||
| EBITDA | 2.75% | 12.00% | |||
| EPS Basic | -- | 100.00% | |||
| Normalized Basic EPS | -- | 100.00% | |||
| EPS Diluted | -- | 100.00% | |||
| Normalized Diluted EPS | -- | 100.00% | |||
| Average Basic Shares Outstanding | 0.00% | 98,809.32% | |||
| Average Diluted Shares Outstanding | 0.00% | 98,809.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
